Patent US5053033A successfully refreshed from Google Patents.
US5053033A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Inhibition of restenosis by ultraviolet radiation
Assignee: Illumenex Corp
•
Filing: 1990-10-10
•
Granted: 1991-10-01
•
Expires: 2010-10-10
Abstract
Abstract Restenosis following angioplasty can be inhibited by reducing the proliferation of smooth muscle cells in the blood vessel walls at an angioplasty site, and such reduction in cell proliferation can be accomplished by irradiating the angioplasty site with radiation in the ultraviolet (UV) wavelength range. The ultraviolet radiation is preferably delivered via an optical fiber or other waveguide incorporated, for example, into a percutaneous catheter. In operation, the ultraviolet radiation kills smooth muscle cells at the site, thereby reducing the risk of restenosis, while minimizing damage to surrounding tissue.
Inventors
- 👤 Richard H. Clarke
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 05:53
CPC Classifications
A; A61; A61N; A61N5/00; A61N5/06; A61N5/0601; A61B; A61B17/00; A61B17/22; A61B2017/22001; A61B2017/22002; A61M; A61M25/00; A61M25/10; A61M25/104; A61N2005/0658; A61N2005/0661
Claims Analysis
Total Claims: 7
Claim 1
Independent Claim
86 words
A method of inhibiting restenosis associated with angioplasty, the method comprising: disposing an optical waveguide means inside a blood vessel; locating the waveguide means adjacent to an angioplasty side within the vessel; and irradiating the angioplasty site with UV radiation having a wavelength ranging from about 240 to about 280 nanometers via said optical means to deliver non-ablative, cytotoxic radiation to smooth muscle cells forming the blood vessel in the vicinity of the angioplasty side thereby reducing susceptibility to restenosis due to blood vessel cell proliferation.
Claim 2
Independent Claim
86 words
A method of inhibiting restenosis associated with angioplasty, the method comprising: disposing an optical waveguide means inside a blood vessel; locating the waveguide means adjacent to an angioplasty side within the vessel; and irradiating the angioplasty site with UV radiation having a wavelength ranging from about 240 to about 280 nanometers via said optical means to deliver non-ablative, cytotoxic radiation to smooth muscle cells forming the blood vessel in the vicinity of the angioplasty side thereby reducing susceptibility to restenosis due to blood vessel cell proliferation.
Claim 3
Dependent Claim
36 words
The method of claim 1 wherein the step of irradiating the angioplasty site further includes irradiating with a laser radiation beam via the optical waveguide means having a wavelength of about 248 to about 268 nanometers.
Claim 4
Dependent Claim
28 words
The method of claim 1 wherein the step of disposing the waveguide means inside a blood vessel further comprises employing a catheter means to carry the waveguide means.
Claim 5
Dependent Claim
33 words
The method of claim 1 wherein the method further comprises delivering ablative radiation having sufficient energy to photodecompose blood vessel plaque via the optical waveguide means to remove plaque at the angioplasty site.
Claim 6
Dependent Claim
38 words
The method of claim 1 wherein the method further comprises disposing a second optical waveguide means inside the blood vessel for delivery of ablative laser radiation having sufficient energy to photodecompose blood vessel plaque at the angioplasty site.
Claim 7
Dependent Claim
32 words
The method of claim 1 wherein the method further comprises employing with said waveguide means an inflation means disposed within the blood vessel for dilation of said blood vessel to perform angioplasty.
References Cited (Backward Citations)
US4800876A
Cited
US4800876B1
Cited
US4848336A
Cited
US4784135A
Cited
US4784132B1
Cited
US4784132A
Cited
US4732148A
Cited
EP0152766A1
Cited
DE3502331A1
Cited
US4799479A
Cited
US4641912A
Cited
US4657014A
Cited
US4862886A
Cited
US4754752A
Cited
US4854315A
Cited
US4905689A
Cited
US4878492A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-30 | 1995-04-01 | 1995-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-30 | 1999-04-01 | 1999-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-30 | 2003-04-01 | 2003-10-01 | $7700.00 | Window Closed / Lapsed |